Back to Results

PT-112-101 A Phase I, Open-Label, Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-122 Injection in Subjects with Advanced Solid Tumors

Primary Objective

This is a clinical trial of PT-112 that will be administered injection which is investigational.

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study

Treatment

Scope

National

Location

University of Colorado Hospital

Principal Investigator
Elaine Lam,  MD, PhD

Elaine Lam, MD, PhD

Study ID

Protocol Number: 14-0151

More information available at ClinicalTrials.gov: NCT02266745

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers